REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 115 filers reported holding REVOLUTION MEDICINES INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,103,546 | -4.4% | 473,394 | -7.6% | 4.08% | +8.8% |
| Q2 2023 | $13,703,624 | +9.9% | 512,285 | -11.0% | 3.75% | +0.2% |
| Q1 2023 | $12,471,503 | +9.6% | 575,785 | +20.5% | 3.74% | +16.7% |
| Q4 2022 | $11,380,839 | +20.3% | 477,785 | -0.4% | 3.20% | +25.9% |
| Q3 2022 | $9,461,000 | +61.9% | 479,785 | +60.0% | 2.54% | +59.8% |
| Q2 2022 | $5,843,000 | -1.3% | 299,785 | +29.2% | 1.59% | +3.2% |
| Q1 2022 | $5,921,000 | +10.8% | 232,101 | +9.4% | 1.54% | +14.9% |
| Q4 2021 | $5,342,000 | -7.4% | 212,231 | +1.2% | 1.34% | -12.3% |
| Q3 2021 | $5,770,000 | -13.3% | 209,731 | 0.0% | 1.53% | +10.0% |
| Q2 2021 | $6,657,000 | -4.1% | 209,731 | +38.7% | 1.39% | -15.4% |
| Q1 2021 | $6,938,000 | +678.7% | 151,231 | +572.1% | 1.65% | +521.1% |
| Q4 2020 | $891,000 | – | 22,500 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $151,966,000 | 28.85% |
| Ponoi II Management, LLC | 685,011 | $18,845,000 | 27.92% |
| Ponoi Management, LLC | 685,011 | $18,845,000 | 16.73% |
| Column Group LLC | 3,347,245 | $92,083,000 | 10.48% |
| TRV GP IV, LLC | 1,419,900 | $39,061,000 | 8.86% |
| Cormorant Asset Management, LP | 3,144,700 | $86,511,000 | 3.52% |
| Boxer Capital, LLC | 3,484,264 | $95,852,000 | 3.35% |
| BVF INC/IL | 2,485,049 | $68,364,000 | 2.67% |
| Casdin Capital, LLC | 2,800,000 | $77,028,000 | 1.92% |
| COMMODORE CAPITAL LP | 226,228 | $6,224,000 | 1.64% |